The broad spectrum of bioactive properties of phenolic extracts: a prospective study in three different plants by Jabeur, Inès
  
THE BROAD SPECTRUM OF BIOACTIVE PROPERTIES OF 
PHENOLIC EXTRACTS:  
A PROSPECTIVE STUDY IN THREE DIFFERENT PLANTS 
 
 
Inès Jabeur 
 
Dissertation Presented to the 
Polytechnic Institute of Bragança, Portugal 
To obtain the 
Master Degree in Biotechnological Engineering 
 
 
 
Supervisor: Isabel C.F.R. Ferreira 
Co-supervisors: Rui M.V. Abreu & Lotfi Achour 
 
Bragança 
2016 
 
 
Table of Content 
List of Tables 
List of Figures 
Acknowledgement 
List of Abbreviations 
Abstract  
1 MEDICINAL PLANTS .................................................................................................................. 1 
1.1 Medicinal plants ...................................................................................................................... 1 
1.1.1 The extended use of medicinal plants.............................................................................. 1 
1.1.2 The particular case of Hypericum androsaemum L., Tilia platiphyllos Scop. and 
Equisetum giganteum L. .................................................................................................................. 2 
1.1.2.1 Hypericum androsaemum L. ....................................................................................... 2 
1.1.2.2 Tilia platiphyllos Scop. ................................................................................................ 3 
1.1.2.3 Equisetum giganteum L. .............................................................................................. 4 
1.2 Phenolic compounds as bioactive molecules........................................................................... 5 
1.2.1 Chemical aspects of phenolic compounds ....................................................................... 5 
1.2.2 Reported bioactive properties .......................................................................................... 7 
1.2.2.1 Antioxidant activity of phenolic compounds ............................................................... 7 
1.2.2.2 Antitumor activity of phenolic compounds ................................................................. 7 
1.2.2.3 Anti-inflammatory activity of phenolic compounds ................................................... 8 
1.2.3 The presence of these compounds in Hypericum androsaemum L., Tilia platiphyllos 
Scop. and Equisetum giganteum L. ................................................................................................. 9 
1.3 Bioactive properties of the plants under study ........................................................................ 9 
1.3.1 Antioxidant properties ..................................................................................................... 9 
1.3.2 Antitumor properties ..................................................................................................... 10 
1.3.3 Anti-inflammatory properties ........................................................................................ 11 
1.4 Objectives .............................................................................................................................. 12 
2 MATERIALS AND METHODS .................................................................................................. 13 
2.1 Standards and reagents .......................................................................................................... 13 
2.2 Extracts preparation ............................................................................................................... 13 
2.3 Evaluation of the antioxidant activity .................................................................................... 14 
2.3.1 DPPH radical-scavenging activity assay ....................................................................... 14 
2.3.2 Reducing power by ferricyanide/Prussian blue assay ................................................... 15 
2.3.3 Inhibition of β-carotene bleaching ................................................................................. 16 
2.3.4 Thiobarbituric acid reactive substances (TBARS) assay............................................... 16 
2.4 Evaluation of the anti-inflammatory activity......................................................................... 17 
2.4.1 Cells treatment ............................................................................................................... 17 
 
 
2.4.2 Nitric oxide determination ............................................................................................. 18 
2.5 Evaluation of the cytotoxic activity ....................................................................................... 19 
2.5.1 In tumor cell lines .......................................................................................................... 19 
2.5.2 In non-tumor porcine liver cells (PLP2) ........................................................................ 19 
2.6 Chemical characterization of the extracts .............................................................................. 20 
2.7 Statistical analysis ................................................................................................................. 21 
3 RESULTS AND DISCUSSION.................................................................................................... 22 
3.1 Studies with H. androsaemum ............................................................................................... 22 
3.1.1 Antioxidant activity ....................................................................................................... 22 
3.1.2 Cytotoxic activity in tumor and non-tumor cells ........................................................... 23 
3.1.3 Anti-inflammatory activity ............................................................................................ 24 
3.1.4 Chemical characterization ............................................................................................. 24 
3.2 Studies with T. platyphyllos and E. giganteum ..................................................................... 29 
3.2.1 Antioxidant activity ....................................................................................................... 29 
3.2.2 Cytotoxic activity in tumor and non-tumor cells ........................................................... 29 
3.2.3 Anti-inflammatory activity ............................................................................................ 31 
3.2.4 Chemical characterization ............................................................................................. 31 
4 CONCLUSION ............................................................................................................................. 42 
Reference..................................................................................................................................43 
 
 
List of Tables 
Table 1.The major classes of phenolic compounds in plants (Soto et al., 2015). ................................... 6 
Table 2. In vitro antioxidant, antitumor and anti-inflammatory properties of H. androsaemum ethanol: 
water extract (mean ± SD). .................................................................................................................... 22 
Table 3. Retention time (Rt), wavelengths of maximum absorption in the visible region (max), mass 
spectral data, identification and quantification (mean ± SD) of phenolic compounds in the H. 
androsaemum ethanol:water extract. ..................................................................................................... 28 
Table 4. In vitro antioxidant, antitumor and anti-inflammatory properties of T. platyphyllos and E. 
giganteum ethanol: water extracts (mean ± SD). .................................................................................. 30 
Table 5. Retention time (Rt), wavelengths of maximum absorption in the visible region (max), mass 
spectral data, identification and quantification (mean ± SD) of phenolic compounds in Equisetum 
giganteum extract. ................................................................................................................................. 33 
Table 6. Retention time (Rt), wavelengths of maximum absorption in the visible region (max), mass 
spectral data, identification and quantification (mean ± SD) of phenolic compounds in Tilia 
platyphyllos extract. ............................................................................................................................... 36 
 
List of Figures 
Figure 1. Hypericum androsaemum L.. .................................................................................................. 2 
Figure 2. Tilia platiphyllos Scop.. .......................................................................................................... 3 
Figure 3. Equisetum giganteumL............................................................................................................ 4 
Figure 4. Common phenolic compounds found in medicinal plants. ..................................................... 6 
Figure 5.Dried samples of Equisetum giganteum L.,Hypericum androsaemum L. and Tilia 
platyphyllos Scop. .................................................................................................................................. 14 
Figure 6.Microplate showing the DPPH assay. .................................................................................... 15 
Figure 7.Microplate showing the reducing power assay. ..................................................................... 15 
Figure 8. Test tubes showing the β-carotene bleaching assay before absorbance measurement. ......... 16 
Figure 9. Test tubes showing the TBARS assay before absorbance measurement. ............................. 17 
Figure 10. Microplate showing the anti-inflammatory activity assay. ................................................. 18 
Figure 11.Microplate showing the cytotoxic evaluation assay. ............................................................ 20 
Figure 12. Phenolic compounds profile of the H. androsaemum ethanol:water extract recorded at 280 
nm. The numbering correspond to the peak number presented in Table 3............................................ 27 
Figure 13. Phenolic compounds profile of E. giganteum recorded at 370 nm (A) and T. platyphyllos 
recorded at 370 and 280 nm (B). The numbering correspond to the peak number presented in Tables 5 
and 6. ..................................................................................................................................................... 35 
 
 
 
 
 
 Acknowledgements 
First of all, I would like to express my deepest gratitude and sincere thanks to my supervisor 
Prof. Isabel C.F.R. Ferreira for giving me the opportunity to carry out my research 
project in a very good working environment at the Mountain Research Centre (CIMO), ESA, 
Polytechnic Institute of Bragança Portugal. You offered continuous advices and 
encouragement and I benefitted from your knowledge and scientific experience. I appreciate 
your effort and I want to thank you for your guidance, kindness and continuous availability.  
I would also like to express my special thanks to my co-supervisor Prof. Lotfi Achour of 
the Laboratoire de Recherche “Bioressources: Biologie Intégrative & Valorisation”, Institut 
Supérieur de Biotechnologie de Monastir, Tunisia. Despite the distance you have been of 
great help for the successful completion of this project. I hope these few lines make you feel 
the immense respect that I have for you. Thank you so much. 
I would also like to express my sincere appreciation to Dr. Rui M.V. Abreu for co-
supervising this research work. I appreciate your advice and encouragement.  
I also want to thank all researchers of the Mountain Research Centre (CIMO), ESA, 
Polytechnic Institute of Bragança and the Biochemcore research group for all their advice and 
encouragement. Special thanks to Dr. Lillian Barros, Dr. Ricardo C. Calhelha, 
Dr. Josiana Vaz and Dr. Ângela Fernandes. 
I also want to commend the Erasmus+ ICM program for giving me the opportunity to study in 
one of the most multicultural institutes in Portugal. It has been a wonderful experience for me 
and I want to use this opportunity to thank all the teaching and non-teaching staff of the 
Polytechnic Institute of Bragança for providing such a good atmosphere for learning. 
My sincere thanks also goes to the scientific commission of the Biotechnological Engineering 
master’s programme and to all my professors for their support, advices and criticism that 
guided me to successfully complete this programme. 
I dedicate this thesis to my parents, Mohamed Jabeur, Radhia, Zayati, and my 
sisters Sirine, Houda,  Amira  and  Zaineb because without them this dream would 
not have been fulfilled. I want to thank them for their encouragement and moral support. I 
wish that God protect them for me. 
 
 
I finally, want to thank my friends who helped me in one way or the other to achieve my 
dreams and successfully complete this research work. I will never forget all their efforts. Deep 
thanks! 
My gratitude is to God for giving me the opportunity to successfully complete this research 
work and make my dreams come true. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
List of Abbreviations  
λ max       Wavelengths of maximum absorption 
5-LOX      5-Lipooxygenase 
A               Absorbance of the control 
B               Absorbance of the sample solution 
ADPPH        Absorbance of DPPH solution 
AS              Absorbance of sample 
CBI           β-Carotene bleaching inhibition  
CE             Collision energy  
CES           Collision energy spread  
COX-2      Cyclooxygenase-2 
DNA         Deoxyribonucleic acid  
DPPH        2,2-Diphenyl-1-picrylhydrazyl  
DMEM      Dulbecco’s modified Eagle’s minimum essential medium 
DMSO       Dimethyl sulfoxide 
DP             Declustering potential  
EC50           Extract concentration achieving 50% of antioxidant/anti-inflammatory activity 
ECACC     European collection of animal cell culture  
EMS          Enhanced mass spectrometer 
EPI            Enhanced product ion 
FBS           Fetal bovine serum 
GI50           Extract concentration achieving 50% of growth inhibition in cell lines 
HBSS        Hank’s balanced salt solution  
HepG2      Hepatocellular carcinoma cells 
HeLa         Human cervical carcinoma cell line 
HPLC        High performance liquid chromatography  
IC50               Extract concentration achieving 50% of antioxidant/anti-inflammatory activity 
ICAM-1    Intercellular adhesion molecule-1 
IL-1β         Interleukin 1β 
IL-6           Interleukin 6 
IL-8           Interleukin 8 
iNOS         Inducible nitric oxide synthase 
LPI            Lipid peroxidation inhibition 
 
 
LPS           Lipopolysaccharide 
MCF-7      Breast carcinoma cells 
MDA        Malondialdehyde 
MS            Mass spectrometer  
NCI-H460 Non-small cell lung cancer cells 
NED          N-(1-napthyl) ethylenediamine hydrochloride 
NF-κβ        Nuclear factor-κB 
NO            Nitric oxide 
PDA          Photodiode array detector 
PGE2        Prostaglandin E2 
PI3K         Phosphoinositide 3-kinase 
PLP2        Non-tumor liver cells 
RNS          Reactive nitrogen species  
ROS          Reactive oxygen species 
RP            Reducing power  
RSA          Radical-scavenging activity  
RSS           Reactive sulphur species 
Rt              Retention time 
SD             Standard deviation 
SRB           Sulforhodamine B 
TCA          Trichloroacetic acid  
TNF-α       Tumour necrosis factor α 
UV             Ultraviolet  
WHO         World health organization 
 
 
Abstract 
Medicinal plants have received great attention in the last years because of their richness in 
bioactive compounds responsible for different biological activities. In the present study, 
hydroethanolic extracts of Hypericum androseamum L., Equisetum giganteum L. and Tilia 
platyphyllos Scop., were chemically characterized in terms of phenolic composition and 
evaluated for their antioxidant, antitumor and anti-inflammatory properties. All three 
medicinal plants displayed antioxidant activity as free radical scavengers but mainly as lipid 
peroxidation inhibitors. The extracts were also effective in inhibiting nitric oxide production, 
as an indicator of the anti-inflammatory potential, displayed antitumor properties in breast 
carcinoma (MCF-7), non-small cell lung cancer (NCI-H460), cervical carcinoma (HeLa) and 
hepatocellular carcinoma (HepG2) cell lines and, up to the maximal tested concentration, did 
not show any cytotoxic effects for non-tumor cells. 5-O-Caffeoylquinic acid and 3-O-
caffeoylquinic acid were the most abundant phenolic compounds identified in the H. 
androsaemum extract, and might be responsible for the observed bioactivity. Protocatechuic 
acid and epicatechin were most abundant in the T. platyphyllos extract, while kaempferol-O-
glucoside-O-rutinoside was the most abundant phenolic compound in the E. giganteum 
extract. The results showed that these medicinal plants displayed very interesting bioactivities, 
which are related with phenolic composition and quantity. However, it would be interesting to 
evaluate the in vivo efficacy of these plant extracts, as also their mechanisms of action, in 
order to establish real therapeutic doses. 
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1 MEDICINAL PLANTS 
1.1 Medicinal plants 
1.1.1 The extended use of medicinal plants 
Natural resources like plants are currently used all over developed and under developed 
countries of the world as traditional home remedies and are promising agents for drug 
discovery as they play crucial role in traditional medicine. The use of plants for medicinal 
purpose usually varies from country to country and region to region because their use depends 
on the history, culture, philosophy and personal attitudes of the users (Ahmad et al., 2015). 
The use of plants and plant products as drugs predates the written human history (Hayta et al., 
2014). Plants are a very important resource for traditional drugs and around 80% of the 
population of the planet use plants for the treatment of many diseases and traditional herbal 
medicine accounts for 30-50% of the total medicinal consumption in China. In North 
America, Europe and other well-developed regions over 50% of the population have used 
traditional preparations at least once (Dos Santos Reinaldo et al., 2015). 
Medicinal plants have been used over years for multiple purposes, and have increasingly 
attract the interest of researchers in order to evaluate their contribution to health maintenance 
and disease’s prevention (Murray, 2004). Recently between 50,000 and 70,000 species of 
plants are known and are being used in the development of modern drugs. Plants were the 
main therapeutic agents used by humans from the 19th century, and their role in medicine is 
always topical (Hayta et al., 2014). 
The studies of medicinal plants are rapidly increasing due to the search for new active 
molecules, and to improve the production of plants or bioactive molecules for the 
pharmaceutical industries (Rates, 2001). Several studies have been reported, but numerous 
active compounds directly responsible for the observed bioactive properties remain unknown, 
while in other cases the mechanism of action is not fully understood. 
According to the WHO 25% of all modern medicines including both western and traditional 
medicine have been extracted from plants, while 75% of new drugs against infective diseases 
that have arrived between 1981 and 2002 originated from natural sources, it was reported that 
the world market for herbal medicines stood at over US $60 billion per year and is growing 
steadily (Bedoya et al., 2009). Traditional medicine has an important economic impact in the 
21st century as it is used worldwide, taking advantage on the low cost, accessibility, 
flexibility and diversity of medicinal plants (Balunas & Kinghorn, 2005). 
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1.1.2 The particular case of Hypericum androsaemum L., Tilia platiphyllos Scop. 
and Equisetum giganteum L. 
1.1.2.1 Hypericum androsaemum L. 
Hypericum androsaemum L. (Hypericaceae family), commonly known as “Tutsan”, is a 
medicinal plant species growing in damp or shady places in Europe (Valentão et al., 2004). 
Several studies on anti-depressive, anti-inflammatory, antitumor, antimicrobial, antioxidant 
and antiviral benefits of Hypericum perforatum L. have been reported (Rainha et al., 2011; 
Nogueira et al., 2013).  
 
 
Figure 1. Hypericum androsaemum L. (http://luzcardoso.blogspot.pt/2009/02/hipericao -do-
geres-hypericum.html).  
 
 
3 
 
However, based on recent findings, other Hypericum species have also revealed very 
interesting functional properties. Hypericum androsaemum L. (Figure 1), commonly known 
as sweet-amber, has a popular use as cholagogue, hepatoprotector, nephroprotective and 
diuretic (Guedes et al., 2003). Hypericum genus (Hypericaceae) includes 18 species, among 
which 15 have spontaneous grow, and can be found in three regions in Portugal (three in 
Azores, one in Madeira and eleven in mainland) (Ramalhete et al., 2016). H. androsaemum 
has been used in traditional herbal medicine by different cultures. In the Portuguese folk 
medicine, the plant known locally as “Hipericão do Gerês”, is known for its diuretic effect 
and leaf infusions are used for liver, kidneys and bladder diseases. In Britain and France, 
Tutsan means “all-healthy”, or “all heal” due to its medicinal properties. In England the 
pounded leaves are mixed with lard to get an ointment for wounds and dressing cuts (Caprioli 
et al., 2016).   
1.1.2.2 Tilia platiphyllos Scop. 
Tilia platiphyllos Scop. is a flowering plant in the family of Tiliaceae, native to most of the 
temperate Northern Hemisphere, Asia, Europe and North America; covers virtually the entire 
continent of Europe except for large parts of Scandinavia and it is absent in western North 
America. T. platyphyllos (Figure 2) is often planted as an ornamental tree in parks and as a 
shade or lawn tree. They are resistant to drought, dry winds and low temperatures; they are 
suitable for planting and trade protection (Radoglou et al., 2008). 
 
 
Figure 2. Tilia platiphyllos Scop. (http://eattheplanet.org/wp -
content/uploads/2013/09/Tilia_americana_NRCS -1.jpg). 
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T. platiphyllos, is one of lime flower species used as a traditional medicinal plant in Europe 
and Latin America mainly as sedatives and tranquilizers. Based on its medicinal benefit, 
infusions of their inflorescences are used to prepare tea (Cotrim et al., 1999). It has been 
reported to have antispasmodic properties, being used since ancient times for treatment of 
diseases such as hypertension associated with atherosclerosis and nervous tension (Karioti et 
al., 2014), migraine, cold fever, hysteria and blood pressure (Ropiak et al., 2016). Also 
because of their soothing and hydrating properties, extracts of this plant may find application 
in the phytocosmetic industry (Karioti et al., 2014). 
1.1.2.3 Equisetum giganteum L. 
Equisetum giganteum L. (Equisetaceae Hippocrates subgenus), also called “cavalinha”, 
“caballo de cola”, “horsetail” or “giant horsetail” (Francescato et al., 2013). It is a lower 
vascular plant found in Southern and Central America (Danielski et al., 2007).  
 
 
Figure 3. Equisetum giganteumL. (http://gardenofeaden.blogspot.pt/2013/06/the -giant-
horsetail-equisetum-giganteum.html) .  
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This species is used mainly in Mexico, Guatemala, Venezuela, Argentina and other countries 
as traditional medicine. The aerial parts have been widely used as a diuretic in herbal 
medicine with no oral toxicity observed, to treat liver and urinary disorders and as food 
supplements. E. giganteum (Figure 3) was characterized for the first time in Argentina and 
was commonly used as a diuretic, hemostatic and astringent. The plant infusion is also 
recommended for diarrhea, gonorrhea and to cure kidney stones as well as for weight loss in 
Brazil and Argentina (Francescato et al., 2013). Due to its high mineral contents and its 
remineralizing properties, the plant is also recommended for the revitalization of fingernails 
and lifeless hair, among other applications (Calvo et al., 2015). 
1.2 Phenolic compounds as bioactive molecules 
1.2.1 Chemical aspects of phenolic compounds 
Plants produce secondary metabolites with bioactive properties, and phenolic compounds 
represent an important group of these compounds. They are usually found in fruits, 
vegetables, herbs, roots, leaves, and seeds and they play vital roles such as structure, innate 
defence system, reproduction or sensorial properties (colour, bitterness, taste and flavour) and 
the amount of phenolic compounds released may increase due to exposure to UV radiation, 
infection by pathogens and parasites and exposure to extreme temperatures (Soto et al., 2015). 
Phenolic compounds are secondary metabolites which are synthesized through the pentose 
phosphate, shikimate and phenylpropanoid pathways (Adeboye et al., 2014). Phenolic 
compounds are the most common secondary metabolites in the plant kingdom and the term 
“Phenol” denotes a chemical structure comprising a phenyl ring bearing one or more hydroxyl 
substituents (Lattanzio, 2013). Phenolic compounds consist of more than one aromatic ring 
bearing and one or more hydroxyl functional groups (Min et al., 2015). 
 Phenolic compounds include a diversified group of molecules with a wide range of chemical 
structures identified as monomeric, dimeric, and polymeric phenolics. Several classes of 
phenolic compounds (Table 1) have been categorized on the basis of their basic carbon 
skeleton ranging from phenolic acids, flavonoids, tannins, stilbenes, curcuminoids, coumarins, 
lignans, and quinones (Figure 4) and the amount of phenolic compound in each plant usually 
depends on several factors such as cultivation techniques, cultivar, growing conditions, 
ripening process, processing and storage conditions (Lattanzio, 2013). 
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Table 1.The major classes of phenolic compounds in plants (Soto et al., 2015). 
Phenolic compound Basic skeleton  Examples 
Simple phenol, Benzoquinones C6 Catechol, hydroquinone 
Phenolic acids C6—C1 Gallic, salicylic acids 
Acetophenone, Phenylacetic acid C6—C2 Tyrosol, p-hydroxyphenylacetic  
Hydroxycinnamic acid, Coumarins, 
Phenylpropanes, Chromones 
C6—C3 Caffeic, ferulic, myristicin, 
eugenol, eugenin, bergenon  
Naphthoquinones C6—C4 Juglone, plumbagin 
Xanthones C6—C1—C6 Mangiferin 
Stilbenes, Anthraquinones C6—C2—C6 Emodin resveratrol 
Flavonoids, Isoflavonoids, Neoflavonoids C6—C3—C6 Quercetin, cyanidin, Genistein 
Bi, tri, flavonoids (C6—C3—C6)2,3 Amentoflavone 
Lignans, Neolignans (C6—C3)2 Pinoresinol, eusiderin 
Lignins, Catechol melanins (C6—C3)n,   (C6)n Guaiacyl lignins 
Condensed tannins (C6—C3—C6)n Procyanidins, propelargonidins 
 
 
Figure 4.  Common phenolic compounds found in medicinal plants .  
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1.2.2 Reported bioactive properties 
As previously mentioned, phenolic compounds and their derivatives are one of the most 
important groups of secondary metabolites in plants, with several various physiological 
functions (Vidović et al., 2015). Many phenolic compounds have been reported to have potent 
anticarcinogenic, antimutagenic, antiatherosclerotic, antihypoglycemic, antibacterial, 
antifungal, antiviral, anti-thrombotic, cardioprotective and vasodilatory effects as well as 
antioxidant, antitumor and anti-inflammatory activities (Wojdyło et al., 2007; dos Santos 
Reinaldo et al.,2015; Touati et al., 2015). 
1.2.2.1 Antioxidant activity of phenolic compounds 
Phenolic acids are composed mainly of hydroxycinnamic and hydroxybenzoic acid 
derivatives. They are usually present in plant materials as esters and glycosides. Their 
antioxidant potential has been known to be due to their free radical scavenging property over 
hydroxyl, peroxyl radical, superoxide anion and peroxynitrites and also due to their chelating 
effect. Hydroxybenzoic acid derivatives include gallic acid and several tannins while 
hydroxycinamic derivatives and many others include coumaric, caffeic and ferulic acids 
(Carocho & Ferreira, 2013a). Phenolic compounds have been reported by Martins et al. 
(2016) to display promising antioxidant potential and the study of antioxidant properties of 
phenolic extracts of plant origin is one of the hottest subjects for researchers. They also 
reviewed several phenolic compounds (commercial and isolated compounds) from plant and 
concluded that anthocyanins, hydroxybenzoic and hydroxycinnamic acids derivatives are the 
most studied phenolic compounds. Flavonoids have also shown a wide range of biochemical 
and anti-allergic effects, but the most important biological activity of these compounds is the 
capacity to act as antioxidants (Karakaya & Nehir, 1999). 
1.2.2.2 Antitumor activity of phenolic compounds 
Phenolic compounds represent one of the most studied compounds worldwide because of 
their reported beneficial effect in promoting and maintaining good health. Several in vitro and 
in vivo studies have reported the important role of phenolic compounds in the fight against 
cancer and among them are gallic acid, ellagic acid, ferulic acid, caffeic acid, cinnamic acid, 
courmarin, 7-hydroxycoumarin dicoumarol, β-mangostin, arbutin, forbesione, gambogic acid, 
resveratrol, kraft lignins, quercetin, flavone acetic acid, catechin and genistein (Carocho & 
Ferreira, 2013b). Some of the mechanisms of antitumor activity have been known although 
some are still not fully understood. Carocho & Ferreira (2013b) reviewed the anticancer 
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activity of several phenolic compounds, measured in vitro or in vivo, and reported the 
individual mechanism of antitumor action. Most of the compounds were reported to prevent 
activation of PI3K/Akt pathway usually associated with colon cancer, inhibit growth of cells 
by decreasing the hyper phosphorylation of the protein retinoblastoma, apoptosis and DNA 
damage of the cancer cells and finally causing tumor inhibition. Some of these compounds 
have been isolated and separated from natural products and have been clinically tried without 
negative effect or toxicity to the patient but the procedure is faced with several challenges 
allowing for more and more studies to be conducted. 
1.2.2.3 Anti-inflammatory activity of phenolic compounds 
Natural products such as plants, mushrooms, rhizomes and marine algae are an important 
source for isolating and developing potential therapeutic compounds that display anti- 
inflammatory effect with less toxicity. Some of these matrices have been known to display 
activity but it is also important to identify the bioactive metabolites that are responsible for 
this activity. Polysaccharides, terpenes, phenolic compounds, steroids and fatty acids are 
among the highlighted bioactive compounds. In particular, some of the phenolic compounds 
reported to display anti-inflammatory activity are benzenoids, syringaldehyde, syringic acid, 
cinnamic acid, protocathechuic acid and ethynylbenzene (Taofiq et al., 2016). 
The NF-κB is a transcription factor that regulates the expression of several pro-inflammatory 
cytokines and enzymes such as IL-1β, TNF-α, iNOS, and COX-2 that are important in the 
inflammatory process. The mechanism of anti-inflammation by this natural compounds has 
been associated with a reduction in the release of nitric oxide (NO) and other inflammatory 
mediators such as interleukins (IL 1β, IL-6, IL-8), tumor necrosis factor (TNF-α) and 
prostaglandin E2 (PGE2) from inflammatory cells. Several phenolic compounds such as 
flavonoids have been reported to display anti-inflammatory activity by inhibition of NF-κB 
pathway by preventing phosphorylation of IkB protein thereby causing reduction in cytokine 
release (Taofiq et al., 2016). These natural inhibitors of NF-κB are becoming a target for 
researchers and can be further studied and used to treat and prevent various inflammatory 
diseases. 
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1.2.3 The presence of these compounds in Hypericum androsaemum L., Tilia 
platiphyllos Scop. and Equisetum giganteum L. 
The composition of H. androsaemum in terms of phenolic compounds has been reported by 
several authors, namely in aqueous (Valentão et al., 2004) and methanolic (Porzel et al., 2013) 
extracts from leaves and aerial parts of the plant (Rainha et al.,2011; Ramalhete et al., 2016). 
Many studies of H. androsaemum reported the presence of several phenolic compounds such 
as flavonoids, phenolic acids (Caprioli et al., 2016) and xanthones which are usually present 
in the roots and its leaves (Valentão et al., 2002). 
There are also reports on T. platyphyllos phenolics namely flavonol glycosides that together 
with mucilage components have been pointed out as the active ingredients responsible for 
bioactive/medicinal properties of this plant (Toker et al., 2001; Stef et al., 2010; Karioti et al., 
2014). 
E. giganteum shows the presence of phenolic compounds derived from caffeic and ferulic 
acids and flavonoid glycosides such as kaempferol and quercetin derivatives, in addition to 
styrylpyrone (Alavarce et al., 2015). Several studies report the presence of high amounts of 
phenolic compounds, such as flavones, isoflavones, flavonols and flavanols in this plant 
(Danielski et al., 2007). 
1.3 Bioactive properties of the plants under study 
1.3.1 Antioxidant properties 
Free radicals are atoms, molecules or ions with unpaired electrons that are highly unstable and 
active towards chemical reactions with other molecules. They are derived from three 
elements: oxygen, nitrogen and sulphur, thus creating reactive oxygen species (ROS), reactive 
nitrogen species (RNS) and reactive sulphur species (RSS). Antioxidants provide a balance 
between the production and scavenging of ROS and when there is a disruption in this balance, 
there is over overproduction of ROS and the cells start to suffer the consequences of oxidative 
stress (Carocho & Ferreira, 2013a). 
Oxidative stress is a term that defines an imbalance between oxidants antioxidants and pro-
oxidants potentially leading to damage of cell components and has been suggested as the main 
cause of aging, cancer and other diseases in humans. Now modern medicine considers the 
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balance between oxidation and antioxidation a crucial concept in maintaining healthy 
biological system (Rahman et al., 2012). 
The antioxidant activity of plant extracts is of particular interest because of their beneficial 
physiological activity on human health and due to the great potential to replace synthetic 
antioxidants used in medicines and food supplements (Stef et al., 2010). 
Previous studies on H. androsaemum infusion showed strong antioxidant activity against 
several free radicals namely against superoxide anion radical, hydroxyl radical and 
hypochlorous acid (Valentão et al., 2004). The antioxidant potential of H. androsaemum 
aqueous extracts prepared from the whole plant (Hernandez et al., 2010; Ramos et al., 2013), 
aerial parts (Rainha et al., 2011) and leaves (Valentao et al., 2002) has been described. In 
addition, the hepatoprotective effects of aqueous extracts obtained from leaves were also 
reported, which were directly correlated with the antioxidant potential of this plant (Valentão 
et al., 2004). 
The radical scavenging capacity of ethanolic extracts of T. platyphyllos was also previously 
reported (Stef et al., 2010). Water and ethanolic extracts of E. giganteum were also previously 
studied and show remarkable antioxidant activity that are explained by the presence of high 
amounts of phenolic compounds (Nagai et al., 2005). In vitro and in vivo antioxidant activities 
of aqueous extract from leaves and flowers of T. platyphyllos were previously reported and 
related with the abundance of phenolic compounds among them are quercetin and kaempferol 
derivatives (Majer et al., 2014; Yayalaci et al., 2014). 
1.3.2 Antitumor properties 
Cancer is characterized by uncontrolled cell growth and acquisition of metastatic properties. 
In this process, the activation of oncogenes or the inactivation of tumor suppressor genes lead 
to cell cycle arrest and apoptotic pathway (Han et al., 2015). Cancer cells are known to have 
alterations in multiple cellular signalling pathways, and because of the complex 
communications between these signalling networks, the cure of most human cancers remains 
a great challenge. It is the world’s second biggest killer after cardiovascular disease and there 
is an increase attention on isolation of biologically active compounds from plant for anti-
cancer treatment (Chatterjee et al., 2011). Approximately 60% of drugs currently used for 
cancer treatment have been isolated from natural products with a composite mixture of 
compounds present in the whole plant and they have shown potent anticancer properties with 
less cytotoxicity effect compared to conventional drugs (Solowey et al., 2014). 
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The antitumor potential of H. androsaemum aqueous extracts was previously studied (Xavier 
et al., 2012) through the evaluation of its anti-proliferative and pro-apoptotic effects in human 
colorectal cancer cells. Also Dias et al. (2000) reported that H. androsaemum displayed potent 
antitumor activity in vivo. Recent studies show that water extracts of this plant have protective 
effect against oxidative damage of DNA responsible for the induction of colon carcinogenesis 
(Ramos et al., 2013). No reports could be found for the antitumor activity of extracts of T. 
platyphyllos and E. giganteum. 
1.3.3 Anti-inflammatory properties 
Inflammation is a complex biological response to remove harmful stimuli such as pathogens, 
damaged cells, or irritation from the body and this is usually associated with many diseases 
such as atherosclerosis, obesity, metabolic syndrome, and diabetes (Taofiq et al., 2015).When 
body cells get in contact with immune stimulants such as pathogens, inflammatory cells like 
macrophages, monocytes secrete cytokines and other mediators, which initiate the 
inflammation process. The common inflammatory mediators are interleukins (IL-1β, IL-6, IL-
8), tumour necrosis factor (TNF-α), nuclear factor-κB (NF-κB), intercellular adhesion 
molecule-1 (ICAM-1), inducible type cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), 
5-lipooxygenase (5-LOX), and inducible nitric oxide synthase (iNOS) that leads to the 
production of reactive nitrogen species such as nitric oxide (NO). Overproduction of these 
inflammatory mediators leads to different kinds of cell damage (Kanwar et al., 2009). 
Research studies are focused on finding plant extracts and their bioactive compounds that 
have the ability to suppress the production of inflammatory mediators through down 
regulation of the gene expression of different types of inflammatory mediators (Souza et al., 
2015). 
Some studies have shown that ethanol extracts of the aerial parts of H. androsaemum possess 
anti-inflammatory activity (Šavikin et al., 2007). E.giganteum decoction and infusion are 
widely used in traditional medicine in inflammatory conditions (Nagai et al., 2005; Farinon et 
al., 2013; Alavarce et al., 2015). No reports could be found for the anti-inflammatory activity 
of extracts of T. platyphyllos.  
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1.4 Objectives 
The main objective of the present study was to perform a prospective study of the bioactive 
compounds and properties in plants used in the traditional medicine, and contribute to 
increase scientific evidences of their uses. 
The specific objectives were: 
To evaluate the in vitro antioxidant, antitumor and anti-inflammatory properties of 
hydroethanolic extracts of Hypericum androsaemum L., Tilia platiphyllos Scop., and 
Equisetum giganteum L.; 
To chemically characterise the extracts in terms of phenolic compounds and correlate the 
composition with the observed bioactive properties.  
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2 MATERIALS AND METHODS 
2.1 Standards and reagents 
HPLC grade acetonitrile 99.9% and analytical grade purity ethanol were from Fisher 
Scientific (Lisbon, Portugal). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa 
Aesar (Ward Hill, MA, USA). Formic acid, trolox (6-hydroxy-2,5,7, 8-tetramethylchroman-2-
carboxylic acid), sulforhodamine B, trypan blue, trichloroacetic acid (TCA) and Tris were 
from Sigma Chemical Co. (St. Louis, MO, USA). Dulbecco’s modified Eagle’s medium, 
Hank’s balanced salt solution (HBSS), fetal bovine serum (FBS), L-glutamine, trypsin-
EDTA, penicillin/streptomycin solution (100 U/mL and 100 mg/ mL, respectively), were 
purchased from Gibco Invitrogen Life Technologies (California, USA). RAW264.7 cells were 
purchased from ECACC (“European Collection of Animal Cell Culture”) (Salisburg, UK), 
lipopolysaccharide (LPS) from Sigma and DMEM medium from HyClone. The Griess 
Reagent System Kit was purchased from Promega, and dexamethasone from Sigma. Water 
was treated in a Milli-Q water purification system (TGI Pure Water Systems, Greenville, SC, 
USA).  
 
2.2 Extracts preparation 
Aerial parts of Equisetum giganteum L., Tilia platyphyllos Scop. And Hypericum 
androsaemum L. (Figure 5) were provided by “Cantinho das Aromáticas”, an organic and 
certified farm from Vila Nova de Gaia, Portugal. The dried samples were reduced to powder 
and submitted to the following extraction procedure in three independent experiments: 4 g 
were stirred with 30 mL of ethanol: water (80:20, v/v) for 1 h, filtered and re-extracted in the 
same conditions. Ethanol was removed in a rotary evaporator (Büchi R-210, Flawil, 
Switzerland), while water was removed by lyophilisation. Finally, stock solutions of each 
hydroethanolic extract were prepared: 5 mg/mL in water/ethanol for antioxidant activity 
assays; 8 mg/mL in water for antitumor and anti-inflammatory assays, from which several 
dilutions were performed; and 2.5 mg/mL in ethanol: water (80:20, v/v) for phenolic 
compound analysis (the extract was filtered through a 0.45 μm Whatman syringe filter and 
transferred to amber color HPLC vial). 
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Figure 5.Dried samples of Equisetum giganteum  L.,Hypericum androsaemum  L. and  Tilia 
platyphyllos Scop .  
 
2.3 Evaluation of the antioxidant activity 
Four different assays were used to assess the in vitro antioxidant potential of plant extracts: 
scavenging effects on DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals (RSA), Reducing 
power, measured by ferricyanide Prussian blue assay (RP), β-carotene bleaching inhibition 
(CBI) and lipid peroxidation inhibition (LPI). 
2.3.1 DPPH radical-scavenging activity assay 
This methodology was performed using a 96 well Microplate. The reaction mixture on the 
plate consists of 30 μL of extract solutions with different concentrations and 270 μL methanol 
containing DPPH radicals (6 × 10−5 mol/L). The mixture was left to stand for 1hour in the 
dark, and the absorbance was read at 515 nm in the ELX800 Microplate Reader (Bio-Tek 
Instruments, Inc; Winooski, VT, USA) (Figure 6). The radical scavenging activity (RSA) was 
calculated as a percentage of DPPH discoloration using the equation: %RSA= [(ADPPH − 
AS)/ADPPH] × 100, where AS is the absorbance of the solution containing the sample, and 
ADPPH is the absorbance of the DPPH solution (Fernandes et al., 2014). 
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Figure 6.Microplate showing the DPPH assay. 
 
2.3.2 Reducing power by ferricyanide/Prussian blue assay 
Extract with different concentrations (0.5 mL) were mixed with sodium phosphate buffer (200 
mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 0.5 mL). The mixture was 
incubated at 50 ºC for 20 min, and trichloroacetic acid (10% w/v, 0.5 mL) was added. The 
mixture (0.8 mL) was poured in the 48 wells plate. Deionized water (0.8 mL) and ferric 
chloride (0.1% w/v, 0.16 mL) were added and the absorbance was read at 690 nm in ELX800 
Microplate Reader (Figure 7) (Bio-Tek Instruments, Inc; Winooski, VT, USA) (Fernandes et 
al., 2014). 
 
Figure 7.Microplate showing the reducing power assay. 
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2.3.3 Inhibition of β-carotene bleaching 
A β-carotene solution was prepared by dissolving β-carotene (2 mg) in chloroform (10 mL). 
Afterwards, 2 mL of this solution were pipetted into a round-bottom flask and the chloroform 
was removed at 40 ºC under vacuum and a linoleic acid (40 mg), Tween 80 emulsifier (400 
mg), and distilled water (100 mL) were added to the flask with vigorous shaking. Aliquots 
(4.8 mL) of this emulsion were transferred into test tubes containing (0.2 mL) extract 
solutions with different concentrations. A control was prepared in which extraction solvent 
was added instead of the mushroom extract. The tubes were shaken and incubated at 50 ºC in 
a water bath. As soon as the emulsion was added to each tube, the zero time absorbance was 
measured at 470 nm (Figure 8). The absorbance of the reaction mixture was finally read after 
2 h and the β-carotene bleaching inhibition was calculated using the following equation: 
(absorbance after 2 h of assay/initial absorbance) × 100 (Fernandes et al., 2014). 
 
Figure 8.  Test tubes showing the β -carotene bleaching assay before absorbance measurement .  
 
2.3.4 Thiobarbituric acid reactive substances (TBARS) assay 
Porcine brains were obtained from official slaughtered animals, dissected, and homogenized 
with Polytron in an ice cold Tris-HCl buffer (20 mM, pH 7.4) to produce a 1:2 w/v brain 
tissue homogenate which was centrifuged at 3000 × g for 10 min. An aliquot (100 µL) of the 
supernatant was incubated with the different concentrations of the sample solutions (200 µL) 
in the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL) at 37 ºC for 1 
h. The reaction was stopped by the addition of trichloroacetic acid (28% w/v, 500 µL), 
followed by thiobarbituric acid (TBA, 2%, w/v, 380 µL), and the mixture was then heated at 
80 ºC for 20 min. After centrifugation at 3000 × g for 10 min to remove the precipitated 
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protein, the colour intensity of the malondialdehyde (MDA)-TBA complex in the supernatant 
was measured by its absorbance at 532 nm (Figure 9). The inhibition ratio (%) was calculated 
using the following formula: inhibition ratio (%) = [(A − B)/A] × 100%, where A and B were 
absorbance of the control and the sample solution, respectively (Fernandes et al., 2014). 
The results from each assay were expressed as EC50 values, corresponding to the extracts 
concentration that provides 50% of antioxidant activity, or 0.5 of absorbance in the case of 
reducing power assay. Trolox was used as positive control. 
 
 
Figure 9. Test tubes showing the TBARS assay before absorbance  measurement.  
 
2.4 Evaluation of the anti-inflammatory activity 
2.4.1 Cells treatment 
The anti-inflammatory activity was carried out according to the procedure reported by (Taofiq 
et al., 2015). The mouse macrophage-like cell line RAW264.7 was cultured in DMEM 
medium supplemented with 10% heat-inactivated fetal bovine serum, glutamine and 
antibiotics at 37 °C under 5% CO2, in humidified air. For each experiment, cells were 
detached with a cell scraper. A cell density of 5 × 105 cells/mL was used, and the proportion 
of dead cells was less than 5%, according to Trypan blue dye exclusion test. Cells were 
seeded in 96-well plates at 150,000 cells/well and allowed do attach to the plate overnight. 
Then, cells were treated with the different concentrations of each one of the extracts for 1 h. 
Dexamethasone (50 μM) was used as a positive control for the experiment. The following 
step was the stimulation with LPS (1 μg/mL) for 18 h. The effect of all the tested samples in 
the absence of LPS was also evaluated, in order to observe if they induced changes in nitric 
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oxide (NO) basal levels. In negative controls, no LPS was added. Both extracts and LPS were 
dissolved in supplemented DMEM. 
 
Figure 10 .  Microplate showing the anti-inflammatory activity assay. 
 
2.4.2 Nitric oxide determination 
For the determination of nitric oxide, Griess Reagent System kit was used, which contains 
sulphanilamide, N-(1-napthyl) ethylenediamine hydrochloride (NED) and nitrite solutions. A 
reference curve of the nitrite (sodium nitrite 100 μM to 1.6 μM; y = 0.0066x + 0.1349; R2 = 
0.9986) was prepared in a 96-well plate. The cell culture supernatant (100 μL) was transferred 
to the plate and mixed with sulphanilamide and NED solutions, 5–10 min each, at room 
temperature. The nitric oxide produced was determined by measuring the absorbance at 540 
nm (microplate reader ELX800 Biotek), and by comparison with the standard calibration 
curve (Figure 10).The final results expressed in EC50 values, i.e. the extract concentration that 
inhibited 50% of the NO production. 
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2.5 Evaluation of the cytotoxic activity 
2.5.1 In tumor cell lines 
The human tumor cell lines used were: HeLa (cervical carcinoma), HepG2 (hepatocellular 
carcinoma), MCF-7 (breast adenocarcinoma) and NCI-H460 (non-small cell lung cancer). 
Each of the cell lines were plated in a 96-well plate, at an appropriate density (7.5 × 103 
cells/well for MCF-7 and NCI-H460 and 1.0 × 104 cells/well for HeLa and HepG2) and were 
allowed to attach for 24 h. Afterwards, various extract concentrations were added to the cells 
and incubated during 48 h. Afterwards, cold trichloroacetic acid (TCA 10%, 100 μL) was 
used in order to bind the adherent cells and further incubated for 60 min at 4 ºC. After the 
incubation period, the plates were washed with deionised water and dried and sulforhodamine 
B solution (SRB 0.1% in 1% acetic acid, 100 μL) was then added to each plate well and 
incubated for 30 min at room temperature. The plates were washed with acetic acid (1%) in 
order to remove the unbound SRB and air dried, the bounded SRB was solubilised with Tris 
(10 mM, 200 μL) and the absorbance was measured at 540 nm using an ELX800 microplate 
reader (Bio-Tek Instruments, Inc; Winooski, VT, USA) (Abreu et al., 2011).The obtained 
results were expressed in GI50 values, i.e. the extract concentration that inhibited 50% of the 
net cell growth. Ellipticine was used as positive control. 
2.5.2 In non-tumor porcine liver cells (PLP2) 
Liver tissues were washed in Hank’s balanced salt solution, containing 100 U/mL of 
penicillin and 100 µg/mL of streptomycin, and then divided into 1×1 mm3 explants. Some of 
these explants were placed in 25 cm3 tissue ﬂasks, containing DMEM and supplemented with 
10% fetal bovine serum, 2 mM of non-essential amino acids, 100 U/mL of penicillin and 100 
mg/mL of streptomycin. Subsequently were incubated at 37 ºC, in a humidiﬁed atmosphere 
containing 5% CO2. This medium was changed every 2 days, and the cultivation of cells 
continued under direct monitoring every 2-3 days, by using a phase contrast microscope. Prior 
to conﬂuence, cells were sub-cultured and plated in 96-well plates, with a final density of 
1.0×104 cells/well and cultivated in DMEM medium, consisting of 10% FBS, 100 U/mL of 
penicillin and 100 µg/mL of streptomycin (Abreu et al., 2011). Finally, cells were treated for 
48 h with different diluted sample solutions of each plant extract tested (Figure 11). The 
obtained results were expressed in GI50 values, i.e. the extract concentration that inhibited 
50% of the net cell growth. Ellipticine was used as positive control. 
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Figure 11 .Microplate showing the cytotoxic evaluation assay.  
 
2.6 Chemical characterization of the extracts 
HPLC-DAD–ESI/MSn analyses was performed using a Hewlett-Packard 1100 chromatograph 
(Hewlett-Packard 1100, Agilent Technologies, Santa Clara, CA, US) with a quaternary pump 
and a diode array detector (DAD) coupled to an HP Chem Station (rev. A.05.04) data-
processing station and connected via the cell outlet to a MS detector API 3200 Qtrap (Applied 
Biosystems, Darmstadt, Germany) through an ESI source and a triple quadrupole-ion trap 
mass analyzer that was controlled by the Analyst 5.1 software. Separation was achieved on a 
Waters Spherisorb S3 ODS-2 C18, (3 μm, 4.6 mm × 150 mm) column thermostatted at 35 °C 
was used. The mobile phase consisted of (A) 0.1% formic acid in water, (B) acetonitrile at a 
flow rate of 0.5 mL/min (injection volume 100 µL). Gradient elution was carried out using the 
following timetable: 15% for 5 min, 15% B to 20% B over 5 min, 20-25% B over 10 min, 25-
35% B over 10 min, 35-50% B for 10 min. The resulting total run time was 55 min, followed 
by column reconditioning of 10 minutes. The chromatogram was recorded at several 
wavelengths, characteristic of different classes of polyphenols, such as 280 nm for phenolic 
acids, flavan-3-ols and flavanones, 330 nm for hydroxycinnamic acids and 370 nm for 
flavonols and flavones.  
For MS detection a zero grade air served as the nebulizer gas (30 psi) and turbo gas for 
solvent drying (400 ºC, 40 psi). Nitrogen served as the curtain (20 psi) and collision gas 
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(medium). The quadrupols were set at unit resolution. The ion spray voltage was set at -
4500V in the negative mode. The MS detector was programmed for recording in two 
consecutive modes: Enhanced MS (EMS) and enhanced product ion (EPI) analysis. EMS was 
employed to show full scan spectra, so as to obtain an overview of all of the ions in sample. 
Settings used were: declustering potential (DP) -450 V, entrance potential (EP) -6 V, collision 
energy (CE) -10V. EPI mode was performed in order to obtain the fragmentation pattern of 
the parent ion(s) in the previous scan using the following parameters: DP -50 V, EP -6 V, CE 
-25V, and collision energy spread (CES) 0 V. Spectra were recorded in negative ion mode 
between m/z 100 and 1700 (Souza et al., 2015). 
The phenolic compounds were identified by comparing their retention times, UV-vis and 
mass spectra with those obtained with standard compounds, when available. Otherwise, 
compounds were tentatively identified comparing the obtained information with available 
data reported in the literature. For quantitative analysis, a calibration curve for each available 
phenolic standard: (+)-catechin (y=134.92x+32.987; R2=0.999); caffeic acid (y=359x+488; 
R2=0.998); chlorogenic acid (y=304x-248; R2=0.999); (-)-epicatechin (y=163.23x+39.586; 
R2=0.999); kaempferol-3-O-glucoside (y=236x+70; R2=0.999); kaempferol-3-O-rutinoside 
(y=183x+97; R2=0.999); naringenin (y=539,98x+161,46; R2=0.994); protocatechuic acid (y= 
258.17x+328.45; R2=0.998); quercetin-3-O-glucoside (y=336x+358; R2=0.998) and 
quercetin-3-O-rutinoside (y=281x+374; R2=0.998), was constructed based on the UV signal. 
For the identified phenolic compounds for which a commercial standard was not available, 
the quantification was performed through the calibration curve of another compound from the 
same phenolic group and results were expressed as mg per g of extract. 
2.7 Statistical analysis 
Three samples were used for each preparation and all the assays were carried out in triplicate. 
The results are expressed as mean values ± standard deviation (SD). The results were 
analyzed using a Student´s t-test to determine the significant difference among two different 
samples, with α = 0.05. This treatment was carried out using SPSS v. 22.0 program.
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3 RESULTS AND DISCUSSION 
3.1 Studies with H. androsaemum 
3.1.1 Antioxidant activity 
Numerous studies have been conducted to identify effective antioxidant compounds, 
including their active concentration and related modes of action being currently considered 
one of the highest hot topics among the scientific community (Dato et al., 2013; Espín, 
García-Conesa, & Tomás-Barberán, 2007). In fact, a relation between premature aging, 
longevity impairment and oxidative stress status is known to exist, despite the intensive 
investigation a general consensus was not established (Halliwell, 2012). On this field, 
phenolic compounds seem to be promissory antioxidant agents (Carocho & Ferreira, 2013a; 
Fernandez-Panchon et al., 2008). Thus, aiming to put forward alternative sources of phenolic 
compounds, the present study was carried out to evaluate the antioxidant potential of H. 
androsaemum hydroethanolic extract as an alternative source of phenolic compound using 
four different in vitro assays. The results are given in Table 2. 
Table 2. In vitro antioxidant, antitumor and anti-inflammatory properties of H. androsaemum ethanol: water 
extract (mean ± SD). 
 H. androsaemum *Positive control 
Antioxidant activity (EC50, µg/mL)   
DPPH scavenging activity 96±3 41±1 
Reducing power 103±1 41±2 
β-carotene bleaching inhibition 155±5 18±1 
TBARS inhibition 36±1 23±1 
Antitumor activity(GI50 values, µg/mL)   
MCF-7 (breast carcinoma) 106±11 0.91±0.04 
NCI-H460 (non-small cell lung cancer) 215±13 1.03±0.09 
HeLa (cervical carcinoma) 205±18 1.91±0.06 
HepG2 (hepatocellular carcinoma) 100±7 1.1±0.2 
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Hepatotoxicity (GI50 values, µg/mL)   
PLP2 >400 3.2±0.7 
Anti-inflammatory activity (EC50 values, µg/mL) 
NO production inhibition 179±17 16±1 
*Trolox, ellipticine and dexamethasone for antioxidant, antitumor and anti-inflammatory activity assays, 
respectively. EC50 values correspond to the extract concentration achieving 50% of antioxidant/anti-
inflammatory activity or 0.5 of absorbance in reducing power assay. GI50 values correspond to the extract 
concentration achieving 50% of growth inhibition in human tumour cell lines or in liver primary culture PLP2. 
 
The most significant antioxidant effect was observed in the LPI assay, followed by RSA, RP 
and CBI assays, which means that the studied H. androsaemum extract acts mainly as lipid 
peroxidation inhibitor, followed by radical scavenger and inhibitor of linoleic acid oxidation.  
Rainha et al. (2011) also evaluated the antioxidant potential of aqueous extracts from the 
aerial parts of different Hypericum species and the result are in agreement with the ones 
reported in the present work and the authors concluded that H. androseamum exerted strong 
radical scavenger effect and moderate inhibitory effect of linoleic acid oxidation. Also, 
Valentão et al. (2002) evaluated the antioxidant potential of water extracts prepared from H. 
androseamum leaves and reported their antioxidant action mainly as strong scavengers of 
reactive oxygen species (mainly superoxide radicals). Similar radical scavenging effects of H. 
androseamum aqueous extracts were described by Hernandez et al. (2010) and Ramos et al. 
(2013), being also reported by the last authors a significant ability to repair DNA damages. 
Lastly, Valentão et al. (2004) aiming to directly correlate the hepatoprotective effects of H. 
androseamum with its antioxidant potential, concluded that those effects mainly derived from 
its strong ability to inhibit lipid peroxidation, which was in part attributed to its phenolic 
composition. 
3.1.2 Cytotoxic activity in tumor and non-tumor cells 
The cytotoxicity of H. androseamum was evaluated in non-tumor porcine liver cells (PLP2) 
as also in tumor cell lines (breast carcinoma- MCF-7, non-small cell lung carcinoma- NCI-
H460, cervival carcinoma- HeLa and hepatocellular carcinoma- HepG2), and the results are 
given in Table 2. Up to 400 µg/mL, the H. androseamum extract showed no toxicity in non-
tumor liver cells (PLP2), while ellipticine used as control showed high hepatotoxicity. 
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Otherwise, a relative low concentration of the extracts was necessary to cause 50% of growth 
inhibition in human tumor cell lines. H. androseamum was found to be most potent in MCF-7 
and HepG2 cell lines with GI50 values of 106.03±10.60 µg/mL and 100.27±6.53 µg/mL, 
respectively, while a significant effect was also found against NCI-H460 and HeLa cells. 
Xavier et al. (2012) reported the in vitro anti-proliferative and pro-apoptotic effects of H. 
androsaemum aqueous extracts in human colon carcinoma-derived cell lines, and described 
an IC50 concentration of 65 µg/mL. It is to note that chlorogenic acid was the most abundant 
phenolic compound in the extract studied by those authors (Xavier et al., 2012), which is in 
agreement with the herein tested ethanol:water extract, where two chlorogenic acids, 5-O-
caffeoylquinic acid and 3-O-caffeoylquinic acid were the majority compounds. 
3.1.3 Anti-inflammatory activity 
Inflammation is in the origin of numerous degenerative and metabolic disorders, among 
which the most tremendous is cancer. Notwithstanding, the inflammatory process is a very 
complex process, and in most of the cases the triggering factor cannot be identified, although 
free radicals overproduction might be one of the reasons (Aruoma, 2003; Soobrattee, 
Neergheen, Luximon-Ramma, Aruoma, & Bahorun, 2005). Thus, and considering the 
observed antioxidant potential of the H. androseamum ethanol:water extract of H. 
androseamum was evaluated for inhibition of nitric oxide (NO) production. The results are 
presented in Table 2 and the H. androseamum extract inhibited NO with an EC50 value of 
178.78±16.60 µg/mL while dexamethasone used as positive control inhibited NO production 
with an EC50 value of 15.70±1.1 µg/mL. As far as we know, this would be the first report on 
the anti-inflammatory potential of H. androseamum extracts. 
3.1.4 Chemical characterization 
The chromatographic profile of the H. androsaemum ethanol:water extract recorded at 280 
nm is shown in Figure 12, and peak characteristics, tentative identities and phenolic 
compounds quantification are presented in Table 3. Compounds 2 (protocatechuic acid), 4 (5-
O-caffeoylquinic acid), 6 (epicatechin), 11 (taxifolin), 12 (quercetin-3-O-glucuronide) and 13 
(quercetin-3-O-glucoside) were positively identified by comparison with authentic standards, 
as also by their MS fragmentation pattern, retention time and UV-vis characteristics. 5-O-
Caffeoylquinic acid and quercetin derivatives have been reported in methanol extracts from 
the aerial parts (Rainha et al., 2011) and leaves (Valentão et al., 2003; Porzel et al., 2014) of 
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H. androsaemum, and in aqueous extracts from the leaves (Valentão et al., 2002; Valentão et 
al., 2004). 
Compound 1 ([M-H]-at m/z 353) was identified as 3-O-caffeoylquinic acid based on its 
fragmentation pattern, yielding a base peak at m/z 191 (deprotonated quinic acid) and an ion 
at m/z 179 [caffeic acid-H]- with an intensity of 47% of the base peak, as reported by Clifford 
et al. (2003, 2005). Similarly, compound 3 ([M-H]- at m/z 337) was tentatively identified 
according to its MS2 fragmentation as 3-O-p-coumaroylquinic acid (Clifford et al. 2003, 
2005). These compounds have been already reported in aqueous (Valentão et al., 2002; 
Valentão et al., 2004) and methanolic (Valentão et al., 2003; Porzel et al., 2014) extracts from 
leaves and in aerial parts (Rainha et al., 2011) of H. androseamum. 
Compounds 5, 7, 8 and 10 showed UV spectra with λmax 280 nm, characteristic of 
proanthocyanidins. Peaks 5 and 10 presented pseudomolecular ions corresponding to 
(epi)catechin dimers ([M-H]- at m/z 577) and compounds 7 ([M-H]- at m/z 865) and 8 ([M-H]- 
at m/z 1153) to a trimer and a tetramer, respectively. The positive identification in the extract 
of epicatechin as the only flavan-3-ol monomer would suggest an epicatechin-based identity 
for those peaks. Thus, the compounds might correspond to the B-linked epicatechin series, 
i.e., procyanidin dimer B2 (epicatechin-4,8-epicatechin, peak 5), trimer C1 (epicatechin-4,8-
epicatechin-4,8-epicatechin, peak 7) and the (4,8)-linked epicatechin tetramer (peak 8), 
whereas the late elution of peak 10 suggests a (4,6) linkage (i.e., epicatechin-4,6-epicatechin; 
dimer B5). These identities would also be coherent with their expected relative order of 
elution (Santos-Buelga, García-Viguera, & Tomás-Barberán, 2003). This identification differs 
from the one recently reported by Ramalhete et al., (2016) who indicated the presence of (+)-
catechin and related proanthocyanidins in methanol extracts obtained from the aerial parts of 
this plant. Compounds 14 ([M-H]- at m/z 463) and 15 ([M-H]- at m/z 433) presented UV 
spectra (λmax354-356 nm) and the production of a unique fragment ion at m/z 301 ([quercetin-
H]-), which allowed their identification as quercetin-O-hexoside and quercetin-O-pentoside, 
respectively. Finally, compound 9 ([M-H]- at m/z 449) was tentatively identified as 
eriodictyol-O-hexoside, based on its UV spectrum and the product ion observed at m/z 287. 
No further conclusion about the nature and position of the substituting sugar of these 
compounds can be made from the obtained LC-DAD-MS data. Similar quercetin glycosides 
have been indicated in aqueous (Valentão et al., 2002; Valentão et al., 2004) and methanol 
(Valentão et al., 2003; Porzel et al., 2014; Rainha et al., 2011) preparations of the plant, 
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whereas, to the author’s best knowledge, the presence of eriodictyol-O-hexoside has not been 
previously reported. 
Overall, 5-O-caffeoylquinic acid followed by 3-O-caffeoylquinic acid were the majority 
phenolic compounds present in the H. androsaemum ethanol:water extract, and they should 
account for the observed antioxidant, antitumor and anti-inflammatory  activities. 
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Figure 12.  Phenolic compounds profile of the H. androsaemum  ethanol:water extract recorded at 280 nm.  The numbering correspond to the  peak 
number presented in Table  3. 
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Table 3. Retention time (Rt), wavelengths of maximum absorption in the visible region (max), mass spectral data, identification and quantification (mean ± SD) of phenolic 
compounds in the H. androsaemum ethanol:water extract. 
Compound 
Rt 
(min) 
max 
(nm) 
Pseudomolecular 
ion 
[M-H]- (m/z) 
MS2 
(m/z) 
Tentative identification 
 
Quantification  
(mg/g extract) 
1 5.1 328 353 191(100),179(47),161(5),135(38) 3-O-Caffeoylquinic acid 11.6±0.1 
2 6.1 260,294sh 153 109(100) Protocatechuic acid 4.29±0.001 
3 6.9 312 337 191(25),173(10),163(100),119(65) 3-O-p-Coumaroylquinic acid 0.88±0.01 
4 8.0 328 353 191(100),179(3),161(6),135(4) 5-O-Caffeoylquinic acid 40.1±0.1 
5 9.0 280 577 451(25),425(50),407(100),289(63),287(8) Procyanidin B2 5.6±0.1 
6 11.1 280 289 245(18),203(11),187(4),161(7),137(8) (-)-Epicatechin  6.9±0.2 
7 13.1 280 865 739(4),713(3),577(8),575(4),425(19),407(20),289(23),287(8) Procyanidin C1 3.4±0.2 
8 14.2 280 1153 865(9),863(12),577(25),575(42),289(5),287(9) Epicatechin tetramer 4.4±0.2 
9 17.9 286,336sh 449 287(100) Eriodictyol-O-glucoside 3.7±0.2 
10 19.0 280 577 451(67),425(61),407(100),289(82),287(14) Procyanidin B5 4.8±0.5 
11 19.4 288,340sh 303 285(100),199(12),177(8),150(15),125(35) Taxifolin  3.4±0.1 
12 20.2 350 477 301(100) Quercetin-3-O-glucuronide 4.71±0.01 
13 20.6 354 463 301(100) Quercetin-3-O-glucoside 10.69±0.02 
14 21.0 354 463 301(100) Quercetin-O-hexoside 4.41±0.05 
15 23.7 356 433 301(100) Quercetin-O-pentoside  1.33±0.02 
     Total phenolic acid derivatives 56.9±0.2 
     Total flavonoids 53±1 
     Total phenolic compounds 110±0.5 
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3.2 Studies with T. platyphyllos and E. giganteum 
3.2.1 Antioxidant activity 
The results of the antioxidant activity of hydroethanolic extracts of T. platyphyllos and E. 
giganteum are shown in Table 4. In general, T. platyphyllos evidenced a higher antioxidant 
potential than E. giganteum, both as free radical scavenger and also as lipid peroxidation 
inhibitor, being those results clearly confirmed, respectively, by the lowest RSA, RP, CBI and 
LPI EC50 values. Not least interesting to highlight is that this biological activity seems to be 
directly correlated with the relative abundance in phenolic compounds: for the plant extract 
with higher antioxidant effects, i.e. T. platyphyllos, a high concentration of phenolic 
compounds was found Table 6. Thus, it is feasible to infer that the higher antioxidant 
potential of T. platyphyllos was mainly attributed to their richness in phenolic compounds, 
particularly flavonoids (quercetin and kaempferol derivatives), as shown in Table 6.  
Majer et al. (2014) reported the in vitro antioxidant potential (singlet oxygen scavenging) of 
T. platyphyllos leaf flavonoids and concluded that the sun leaves possess higher myricetin 
content than shade leaves, and that quercetin and myricetin derivatives, mainly occurring as 
rhamnosides, exerted much higher singlet oxygen scavenger effects than kaempferol 
glycosides. In fact, a higher content in quercetin derivatives was observed in T. platyphyllos, 
in detriment of kaempferol derivatives; furthermore, in E. giganteum only vestigial amounts 
of quercetin were determined, being kaempferol the most abundant. On the other hand, 
Yayalaci et al. (2014) evaluating the in vivo antioxidant potential of T. platyphyllos flowers 
against ethanol-induced oxidative stress, concluded that linden flowers were able not only to 
prevent oxidative damage in the studied tissues, but also to inhibit the production of ethanol-
induced free radicals in rats. Thus, and considering the obtained results, it is feasible to 
assume that the antioxidant activity of T. platyphyllos is directly correlated with the relative 
abundance in phenolic compounds, mainly quercetin derivatives. 
3.2.2 Cytotoxic activity in tumor and non-tumor cells 
The cytotoxicity of T. platyphyllos and E. giganteum extracts was evaluated in non-tumor 
porcine liver cells (PLP2) as also in tumor cell lines (breast carcinoma- MCF-7, non-small 
cell lung carcinoma- NCI-H460, cervival carcinoma- HeLa and hepatocellular carcinoma- 
HepG2), and the results are given in Table 4. Neither, E. giganteum nor T. platyphyllos 
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extracts have shown toxicity in non-tumor liver cells (PLP2). Otherwise, a relative low 
concentration of the extracts was necessary to cause 50% of growth inhibition in human 
tumor cell lines. Once again, T. platyphyllos revealed more potency than E. giganteum, for all 
the tested tumor cell lines and T. platyphyllos was found to be most potent against HepG2 
with a GI50 value of 173±13 µg/mL while E. giganteum also displayed the best activity 
against HepG2 with a GI50 value of 239±18 µg/mL. Cytotoxic properties of the mentioned 
extracts were not previously mentioned in literature and it is interesting to highlight that this is 
the first report on the cytotoxicity of T. platyphyllos and E. giganteum extracts. 
Table 4. In vitro antioxidant, antitumor and anti-inflammatory properties of T. platyphyllos and E. giganteum 
ethanol: water extracts (mean ± SD). 
 E.  
giganteum 
T. 
platyphyllos 
t-Students test 
p-value 
Antioxidant activity (EC50 values, µg/mL) 
DPPH scavenging activity (RSA) 123±5 105±1 <0.001 
Reducing power (RP) 136±1 123±7 <0.001 
β-carotene bleaching inhibition (CBI) 202±3 167±2 <0.001 
TBARS inhibition (LPI) 57.4±0.5 55.9±0.4 0.024 
Antitumor activity(GI50 values, µg/mL) 
MCF-7 (breast carcinoma) 250±15 224±19 0.058 
NCI-H460 (non-small cell lung cancer) 258±13 247±22 0.380 
HeLa (cervical carcinoma) 268± 16 195±15 0.001 
HepG2 (hepatocellular carcinoma) 239±18 173±13 0.002 
Hepatotoxicity (GI50values, µg/mL) 
PLP2 >400 >400 - 
Anti-inflammatory activity (EC50 values, µg/mL) 
Nitric oxide (NO) production 239±20 225±22 0.314 
The antioxidant activity was expressed as EC50 values, what means that higher values correspond to lower 
reducing power or antioxidant potential. EC50: Extract concentration corresponding to 50% of antioxidant 
activity or 0.5 of absorbance in reducing power assay. Trolox EC50 values: 41 µg/mL (reducing power), 42 
µg/mL (DPPH scavenging activity), 18 µg/mL (β-carotene bleaching inhibition) and 23 µg/mL (TBARS 
inhibition). Results of the anti-inflammatory activity are expressed in EC50 values: sample concentration 
providing 50% of inhibition of nitric oxide (NO) production. Dexamethasone EC50 value: 16±2 µg/mL. 
Cytotoxicity results are expressed in GI50 values corresponding to the sample concentration achieving 50% of 
growth inhibition in human tumor cell lines or in liver primary culture PLP2. Ellipticine GI50 values: 1.2 µg/mL 
(MCF-7), 1.0 µg/mL (NCI-H460), 0.91 µg/mL (HeLa), 1.1 µg/mL (HepG2) and 2.3 (PLP2).  
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3.2.3 Anti-inflammatory activity 
The anti-inflammatory potential of T. platyphyllos and E. giganteum extracts was evaluated 
through measurement of nitric oxide (NO) production, and the obtained results are presented 
in Table 4. Once again, phenolic composition seems to be most important contributor to the 
anti-inflammatory potential of plant extracts. T. platyphyllos inhibited NO production and 
presented an EC50 value of 225±22 µg/mL which correspond to the concentration of plant 
extract that is necessary to achieve 50% inhibition of NO production and it appears to be more 
effective than E. giganteum with an EC50 value of 239±20 µg/mL. As previously mentioned, 
only Farinon et al. (2013) reported the in vivo anti-inflammatory potential of E. giganteum; 
otherwise, to the author’s best knowledge, no studies were previously reported on the anti-
inflammatory potential of T. platyphyllos. From the present results anti-inflammatory effect of 
T. platyphyllos was markedly higher than that of E. giganteum and therefore, it may be 
considered a potential source of anti-inflammatory agents. 
3.2.4 Chemical characterization 
Table 5 and 6 present the characteristics of the identified phenolic compounds, tentative 
identities and quantification of E. giganteum and T. platyphyllos. The chromatographic profile 
of E. giganteum and T. platyphyllos can be observed in Figure 13. Equisetum giganteum 
presented fourteen phenolic compounds (two phenolic acids and twelve flavonol glycoside 
derivatives), while T. platyphyllos presented to be a more complex matrix in its phenolic 
composition, revealing the presence of thirty-three compounds (three phenolic acids, six 
flavan-3-ol derivatives, twenty flavonol glycoside derivatives, two flavanone and flavone 
derivatives). Compounds 2Tp (protocatechuic acid), 4Eg (caffeic acid), 3Tp (catechin), 4Tp (5-O-
caffeoylquinic acid), 6Tp (epicatechin), 15Tp (quercetin-3-O-rutinoside; rutin), 17Tp (quercetin-
3-O-glucuronide), 10Eg and 20Tp (quercetin-3-O-glucoside; isoquercitrin), 23Tp and 
11Eg(kaempferol-3-O-rutinoside) and 13Eg (kaempferol-3-O-glucoside) were positively 
identified by comparison with authentic standard, as also to their MS fragmentation pattern, 
retention time and UV-vis characteristics. Kaempferol-3-O-glucoside has been reported in 
hydroethanolic extracts of aerial parts of E. giganteum (Francescato et al., 2013; Alavarce et 
al., 2015) as also a quercetin-hexoside (Alavarce et al., 2015) Protocatechuic acid, catechin, 
epicatechin and quercetin-3-O-glucoside have also been found in commercial samples of T. 
platyphyllos from Syria and Tuscany (Karioti et al., 2014). 
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Besides the already mentioned phenolic acid derivatives, 3-O-caffeoylquinic acid (peak 11Tp) 
was also tentatively identified based on its MS2 fragmentation pattern, according to the 
systematic keys provided by Clifford et al (2003) for the identification of chlorogenic acids. 
Phenolic acid derivatives represent 19% of the total phenolic composition of T. platyphyllos. 
The sample of T. platyphyllos presented four compounds 5Tp ([M-H]- at m/z 577), 7Tp ([M-H]- 
at m/z 865), 8Tp ([M-H]- at m/z 1153) and 9Tp ([M-H]- at m/z 1441), with characteristic of 
proanthocyanidins (UV spectra with λmax 280 nm), being assigned as procyanidin dimer, 
trimer, tetramer and pentamer, respectively. Comparison with our library database allowed 
identifying peak 5Tp as procyanidin dimer B2, also reported by Negri et al. (2013) in 
hydroethanolic extracts from leaves of Tilia cordata. These compounds have been reported as 
major compounds in samples of T. platyphyllos by Karioti et al. (2014), in the present study 
these compounds were also present in high amounts, representing 34% of the total phenolic 
content, including (epi)catechin, being (-)-epicatechin the most abundant compound found 
(6.4 mg/g extract). 
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Table 5. Retention time (Rt), wavelengths of maximum absorption in the visible region (max), mass spectral data, identification and quantification (mean ± SD) of phenolic 
compounds in Equisetum giganteum extract. 
 
Tr-traces. 
Compound 
Rt 
(min) 
max 
 (nm) 
Molecular ion  
[M-H]- (m/z) 
MS2 
(m/z) 
Tentative identification 
Quantification 
(mg/g extract) 
1Eg 7.2 330 341 179(100) Caffeic acid hexoside 0.131±0.003 
2Eg 9.4 352 625 463(100),301(32) Quercetin-3,7-di-O-glucoside Tr 
3Eg 11.5 348 755 593(100),447(10),285(38) Kaempferol-O-glucoside-O-rutinoside 7.6±0.2 
4Eg 11.9 330 179 135(100) Caffeic acid 4.86±0.03 
5Eg 14.1 348 651 489(33),447(17),285(17) Kaempferol-O-acetylglucoside-O-glucoside 0.087±0.005 
6Eg 14.5 352 667 505(100),301(42) Quercetin-O-acetylglucoside-O-glucoside Tr 
7Eg 15.8 348 651 489(38),447(55),285(56) Kaempferol-O-acetylglucoside-O-glucoside 5.01±0.05 
8Eg 18.8 336 739 593(77),431(10),285(27) Kaempferol-O-rhamnoside-O-rutinoside 0.67±0.04 
9Eg 19.2 348 593 447(41),431(51),285(58) Kaempferol-O-glucoside-O-rhamnoside 1.86±0.02 
10Eg 21.2 358 463 301(100) Quercetin-3-O-glucoside Tr 
11Eg 23.1 348 593 285(100) Kaempferol-3-O-rutinoside 1.95±0.03 
12Eg 23.8 350 635 489(13),431(55),285(31) Kaempferol-O-acetylglucoside-O-rhamnoside 1.77±0.06 
13Eg 24.7 350 447 285(100) Kaempferol-3-O-glucoside 1.81±0.03 
14Eg 30.1 350 489 285(100) Kaempferol-O-acetylglucoside 0.88±0.03 
     Total phenolic acids 4.98±0.03 
     Total flavonoids 21.7±0.4 
     Total phenolic compounds 26.6±0.3 
34 
 
 
 
A  
Time (min) 0 10 20 30 40 50 
mAU 
0 
50 
100 
150 
200 
250 
300 
350 
4
Tp
 10
Tp
 
11
Tp
 
13
Tp
 
14 
15 
16 
19
Tp
 
20
Tp
 
17 
18
Tp
 
21
Tp
 
23
Tp
 
24
Tp
 
25
Tp
 
26
Tp
 
27
Tp
 
28
Tp
 29
Tp
 30
Tp
 
31
Tp
 32
Tp
 
33
Tp
 
370 nm 
Time (min) 
0 10 20 30 40 50 
mAU 
0 
50 
100 
150 
200 
2
Eg
 
3
Eg
 
4
Eg
 
7
Eg
 
5
Eg
 6
Eg
 
8
Eg
 
9
Eg
 
10
Eg
 
11
Eg
 12
Eg
 
13
Eg
 
14
Eg
 
370 nm 
35 
 
B 
 
 
 
 
 
 
 
 
 
 
 
Figure 13.  Phenolic compounds profile of E. giganteum  recorded at 370 nm (A) and T. platyphyllos  recorded at 370 and 280 nm 
(B). The numbering correspond to the peak number presented in Tables 5 and 6. 
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Compound 
Rt 
(min) 
max 
 (nm) 
Molecular ion  
[M-H]- (m/z) 
MS2 
(m/z) 
Tentative identification 
Quantification 
(mg/g extract) 
1Tp 5.1 328 353 191(100),179(44),161(5),135(38) 3-O-Caffeoylquinic acid 0.64±0.03 
2Tp 6.1 260,294sh 153 109(100) Protocatechuic acid 6.3±0.1 
3Tp 7.2 280 289 245(12),203(20),187(10),161(5),137(5) (+)-Catechin  1.6±0.1 
4Tp 8.1 328 353 191(100),179(5),135(6) 5-O-Caffeoylquinic acid 4.7±0.1 
5Tp 9.0 280 577 451(26),425(37),407(100),289(69),287(7) Procyanidin dimer B2 4.2±0.1 
6Tp 11.1 280 289 245(8),203(22),187(11),161(7),137(7) (-)-Epicatechin  6.41±0.01 
7Tp 13.1 280 865 
739(10),713(18),577(34),575(21),425(14),407(25),
289(15),287(20) 
Procyanidin trimer 
2.54±0.02 
8Tp 14.2 280 1153 865(6),863(17),577(61),575(17),289(42),287(10) Procyanidin tetramer 3.9±0.1 
9Tp 15.5 280 1441 1153(9),865(9),577(31),289(96),287(30) Procyanidin pentamer 2.4±0.2 
10Tp 16.3 356 609 463(9),447(27),301(12) Quercetin-O-hexoside-O-deoxyhexoside 0.13±0.01 
11Tp 16.7 356 609 463(20),447(45),301(31) Quercetin-3-O-glucoside-7-O-rhamnoside 1.4±0.1 
12Tp 17.8 286,336sh 449 287(100) Eriodictyol-O-hexoside 1.3±0.1 
13Tp 18.3 358 579 447(64),433(10),301(33) Quercetin-O-pentoside-O-rhamnoside 0.65±0.05 
14Tp 19.2 348 593 447(41),431(54),285(33) Kaempferol-3-O-glucoside-7-O-rhamnoside 1.52±0.02 
15Tp 19.5 356 609 301(100) Quercetin-3-O-rutinoside (rutin) 0.96±0.02 
16Tp 19.8 352 593 446(53),301(39) Quercetin-3,7-di-O-rhamnoside 1.1±0.1 
17Tp 20.2 350 477 301(100) Quercetin-3-O-glucuronide 0.21±0.05 
18Tp 20.5 348 563 431(66),417(26),285(39) Kaempferol-O-pentoside-O-deoxyhexoside 0.76±0.05 
19Tp 20.6 358 463 301(100) Quercetin-3-O-galactoside (hyperoside)  1.01±0.02 
 
Table 6. Retention time (Rt), wavelengths of maximum absorption in the visible region (max), mass spectral data, identification and quantification 
(mean ± SD) of phenolic compounds in Tilia platyphyllos extract. 
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20Tp 21.1 356 463 301(100) Quercetin-3-O-glucoside (isoquercitrin) 6.36±0.04 
21Tp 22.5 360 505 463(12),301(100) Quercetin-3-O-acetylglucoside  0.090±0.004 
22Tp 22.9 284,334sh 433 271(100) Naringenin-O-hexoside 0.90±0.05 
23Tp 23.1 346 593 285(100) Kaempferol-3-O-rutinoside 1.03±0.01 
24Tp 23.4 346 577 431(72),285(78) Kaempferol-3,7-di-O-rhamnoside 1.15±0.03 
25Tp 23.7 356 433 301(100) Quercetin-O-pentoside  1.8±0.1 
26Tp 24.8 350 447 301(100) Quercetin-3-O-rhamnoside (quercitrin) 3.5±0.1 
27Tp 26.1 348 447 285(100) Kaempferol-O-hexoside 0.55±0.03 
28Tp 26.8 352 417 285(100) Kaempferol-O-pentoside 0.38±0.03 
29Tp 29.2 346 431 285(100) Kaempferol-O-rhamnoside 0.39±0.03 
30Tp 30.7 350 431 285(100) Kaempferol-O-rhamnoside 0.45±0.04 
31Tp 32.5 332 283 269(100) Methyl apigenin 2.07±0.01 
32Tp 35.0 316 593 447(10),285(79) trans-Tiliroside  1.38±0.03 
33Tp 35.3 326 593 447(10),285(79) cis-Tiliroside  0.27±0.03 
     Total phenolic acids 11.65±0.05 
     Total flavonoids 50.4±0.4 
     Total phenolic compounds 62.0±0.4 
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Peaks 10Tp, 11Tp, 13Tp, 16Tp, 19Tp, 21Tp, 25 and 26Tp were identified as quercetin derivatives 
owing to the product ion observed at m/z 301 and their UV spectra (max around 350-358 nm). 
Peaks 10Tp and 11Tp both presented the same pseudomolecular ion ([M-H]- at m/z 609) as 
peak 15Tp (quercetin-3-O-rutinoside), but a different fragmentation pattern, as in those 
compounds product ions from the alternative loss of hexosyl (m/z at 447; -162 u) and 
deoxyhexosyl (m/z at 463; -146 u) were observed, indicating their location on different 
positions of the aglycone. Compounds with similar features were reported in T. platyphyllos 
and T. cordata (Negri et al., 2013; Karioti et al., 2014) and identified as quercetin-3-O-
glucoside-7-O-rhamnoside, identity that was tentatively assumed for peak 11Tp in our sample 
owing to its greater concentration, whereas peak 10Tp remained just assigned as quercetin-O-
hexoside-O-deoxyhexoside. Peak 16Tp showed a pseudomolecular ion [M-H]- at m/z 593, 
yielding two fragment ions from consecutive loss of two deoxyhexosyl residues; it was 
tentatively identified as quercetin-3,7-di-O-rhamnoside, a compound commonly reported in 
Tilia species (Toker et al., 2001; Aguirre-Hernández et al., 2010; Negri et al., 2013; Ieri et al., 
2015) including T. platyphyllos (Karioti et al., 2014), whereas peak 13Tp ([M-H]- at m/z 579) 
was tentatively assigned as quercetin-O-pentoside-O-rhamnoside, as reported in T. cordata by 
Negri et al. (2013). Compounds 19Tp ([M-H]- at m/z 463), 25Tp ([M-H]- at m/z 433) and 26Tp 
([M-H]- at m/z 447), presented MS2 fragments corresponding to distinct losses of hexosyl (-
162 u), pentosyl (-132 u) and deoxyhexosyl (-146 u) moieties, and an elution order coherent 
with the type of sugar substituents, according to their expected polarity. Although the position 
and nature of the sugar moieties could not be identified, an identity as quercetin-3-O-
rhamnoside (quercitrin) was assumed for compound 26Tp, previously described in T. 
platyphyllos (Karioti et al., 2014) and other Tilia species (Aguirre-Hernández et al., 2010; 
Negri et al., 2013; Ieri et al., 2015). Similarly, peak 19Tp was tentatively assigned as quercetin-
3-O-galactoside (hyperoside) owing to its previous identification in Tilia tomentosa (Ieri et 
al., 2015) and T. cordata (Kosakowska et al., 2015) that identity would also be supported by 
its close elution to quercetin-3-O-glucoside (peak 20Tp), since galactosides typically elute 
before the equivalent glucosides in RP-HPLC (Santos-Buelga et al., 2003). Peak 21Tp ([M-H]- 
at m/z 505), with a molecular weight 42 u (acetyl residue) higher than compounds 19Tp and 
20Tp was tentatively identified as quercetin-3-O-acetylglucoside, assuming that it could derive 
from the more abundant precursor. 
Peaks 14Tp, 18Tp, 24Tp, 27Tp, 28Tp, 29Tp, 30Tp, 32Tp and 33Tp were identified as kaempferol 
glycosides based on their UV spectra (λmax around 348 nm) and the production of an MS2 
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fragment ion at m/z 285. Tentative identities of these compounds were assigned based on their 
pseudomolecular ions using a similar reasoning as for quercetin derivatives. Thus, peaks 14Tp 
([M-H]- at m/z 593) and 24Tp ([M-H]- at m/z 577) should correspond to kaempferol-3-O-
glucoside-7-O-rhamnoside and kaempferol-3,7-O-dirhamnoside, respectively, compounds 
that have been reported in T. platyphyllos (Karioti et al., 2014) and other Tilia species 
(Aguirre-Hernández et al., 2010; Ieri et al., 2015; Negri et al., 2013; Toker et al., 2004). Peaks 
32Tp and 33Tp possessed the same pseudomolecular ion ([M-H]- at m/z 593) as peaks 14Tp and 
23Tp (kaempferol-3-O-rutinoside), but eluted at a longer retention time. The presence of 
tiliroside (kaempferol-3-O-(6-p-coumaroyl)-glucoside; 6’’-O-(4-hydroxycinnamoyl)-
astragalin) has been consistently reported in different species of Tilia (Toker et al., 2004; 
Aguirre-Hernández et al., 2010; Ieri et al., 2015), including T. platyphyllos. The observation 
in their fragmentation of a product ion at m/z 447, from the loss of p-coumaroyl residue (146 
u) would also be coherent with that identity, as well as the late elution, since the presence of 
the hydroxycinnamoyl residue implies a decrease in polarity. The detection of two peaks 
could be explained by the existence of trans- and cis- isomers of the p-coumaric acid, as also 
noted by Karioti et al. (2014). The more abundant peak 32Tp can be assigned as trans-tiliroside 
taking into account that the form trans is the usual one for p-coumaric acid. Peak 27Tp ([M-
H]- at m/z 447) presented the same pseudomolecular ion as kaempferol-3-O-glucoside 
(astragalin), a compound that was commonly detected in Tilia spp. (Exarchou, Fiamegos, 
Beek, Nanos, & Vervoort, 2006; Aguirre-Hernández et al., 2010; Negri et al., 2013; Karioti et 
al., 2014; Kosakowska et al., 2015), but it eluted at a different retention time, as compared 
with a commercial standard; thus, the detected compound was just assigned as kaempferol-O-
hexoside. Peaks 29Tp and 30Tp, with the same pseudomolecular ion ([M-H]- at m/z 431) 
coherent with kaempferol bearing as deoxyhexosyl moiety. Two undefined kaempferol 
rhamnosides were found in T. tomentosa by Ieri et al. (2015), while the presence of 
kaempferol-3-O-rhamnoside was reported in different Tilia spp. (Aguirre-Hernández et al., 
2010; Karioti et al., 2014; Negri et al., 2013) that could correspond to one of the compounds 
detected in our study. However, since no sufficient information to assign that identity to any 
of the two detected peaks could be obtained, both compounds remain identified as 
kaempferol-O-rhamnoside. The remaining two kaempferol derivatives, i.e., peaks 18Tp and 
28Tp, were respectively assigned as kaempferol-O-pentoside-O-hexoside and kaempferol-O-
pentoside, respectively, based on their mass spectral characteristics. As far as we are aware, 
none of those compounds has been previously reported in Tilia spp. Flavonols accounted for 
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41% of the content of total phenolic compounds, being quercetin-3-O-glucoside the main 
molecule of this group. 
Compounds 12Tp ([M-H]- at m/z 449) and 22Tp ([M-H]- at m/z 433) presented UV spectra 
characteristics of flavanones and MS2 fragments at m/z 287 (eriodictyol) and at m/z 271 
(naringenin), respectively, indicating the loss of an hexosyl residue (162 u), so that they were 
tentatively assigned as eriodictyol-O-hexoside and naringenin-O-hexoside. Finally, peak 31Tp 
showed a pseudomolecular ion [M-H]- at m/z 283 that released an MS2 fragment at m/z 269 
(apigenin, [M-H-14]-) indicating the loss of a methyl group; this observation together with its 
UV spectrum, characteristic of a flavone, suggested that it might correspond to a methyl 
apigenin. To the best of our knowledge, neither flavanones nor flavones have been described 
in T. platyphyllos.  
Equisetum giganteum mainly presented kaempferol derivatives, accounting to 81% of the 
total phenolic content. Thus, in addition to peaks 11Eg and 13Eg, positively identified as 
kaempferol-3-O-rutinoside and kaempferol-3-O-glucoside, peaks 3Eg, 5Eg, 7Eg, 8Eg, 9Eg, 12Eg 
and 14Eg were also assigned as kaempferol-derived compounds based on their UV spectra 
(λmax around 348 nm) and the observation of a product ion at m/z 285; tentative identities were 
attributed from their molecular weight and fragmentation patterns. 
Compound 3Eg ([M-H]- at m/z 755) MS2 fragments revealed the alternative loss of hexosyl 
(m/z at 593; -162 u) and deoxyhexosyl-hexoside (m/z at 447; -308 u) residues, indicating 
location of each residue on different positions of the aglycone. The positive identification of 
kaempferol-3-O-rutinoside and kaempferol-3-O-glucoside may suggest the presence of 
glucosyl and rutinosyl as sugar substituents, so that the compound was tentatively assigned as 
kaempferol-O-glucoside-O-rutinoside. This molecule was the most abundant phenolic 
compound (7.6 mg/g extract) present in this sample. Similarly, compound 8Eg ([M-H]- at m/z 
739) was assigned as kaempferol-O-rhamnoside-O-rutinoside.  
Peaks 5Eg and 7Eg, with the same [M-H]- at m/z 651 and similar fragmentation pattern, with 
production of fragment ions at m/z 489 and 447, from the alternative loss of hexosyl (-162 u) 
and acetylhexosyl residues (-204 u), were assigned as kaempferol-O-acetylglucoside-O-
glucoside. The observation of two compounds might be explained by different substitution 
positions of either each of the two residues on the aglycone or the acetyl moiety on the 
glucose. Compound 9Eg ([M-H]- at m/z 593) showed the same pseudomolecular ion as 
kaempferol-3-O-rutinoside but a different fragmentation pattern. The observation of product 
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ions at m/z 447 (-146 u) and 431 (-162 u) revealed the alternative loss of deoxyhexosyl and 
hexosyl residues, allowing its identification as kaempferol-O-glucoside-O-rhamnoside, 
compound that was reported in extracts of the aerial parts of Equisetum telmateia by Correia 
et al. (2005). Peak 12Eg ([M-H]- at m/z 635) presented a molecular weight 42 u greater than 
peak 9Eg and MS2 fragment ions at m/z 489 (-146 u, loss of a rhamnosyl residue) and 431 (-
204 u, loss of an acetylhexosyl residue), being identified as kaempferol-O-acetylglucoside-O-
rhamnoside. Peak 14Eg, with an [M-H]- at m/z 489 yielding a unique fragment ion at m/z 285, 
from the loss of an acetylhexosyl residue, was assigned as kaempferol-3-O-acetylglucoside, 
compound also reported by Correia et al. (2005) in E. telmateia.  
Peaks 2Eg and 6Eg were assigned as quercetin derivatives based on their absorption spectra and 
the production of a fragment ion at m/z 301. Based on their fragmentation features and 
following a similar reasoning as for the previous kaempferol derivatives, they were assigned 
as quercetin-di-O-glucoside and quercetin-O-acetylglucoside-O-glucoside, respectively. Peak 
2Eg was tentatively identified as quercetin-3,7-di-O-glucoside, owing to the previous 
description of such compound in E. giganteum by Francescato et al. (2013) and Alavarce et 
al. (2015).  
Finally, peak 1Eg was identified as a caffeic acid hexoside according to its UV and mass 
characteristics. 
With the exception of quercetin-3-O-glucoside and kaempferol-3-O-rutinoside, reported in E. 
giganteum by Francescato et al. (2013) and Alavarce et al. (2015), none of the compounds 
detected here in had been previously described in this species. 
The total phenolic compounds, phenolic acids and flavonoids were highly correlated with the 
biological activity of both samples, presenting high correlation factors, especially for DPPH 
scavenging activity (R2=0.89), reducing power (R2=0.66), β-carotene bleaching inhibition 
(R2=0.98), TBARS (R2=0.73), and for the human tumor cell lines HeLa (R2=0.94), HepG2 
(R2=0.93) and MCF-7 (R2=0.62). Confirming the statements mentioned above.  
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4 CONCLUSION 
Medicinal plants have been utilised for several years because of their therapeutic and health 
promoting benefits. The present study revealed that medicinal plants contain a lot of bioactive 
compounds that can be very beneficial in the pharmaceutical industry because of their health 
benefits.  
Ethanol:water extracts of Hypericum androseamum, Equisetum giganteum, and Tilia 
platyphyllos revealed: 
i) Antioxidant activity both as free radical scavengers and lipid peroxidation 
inhibitors; 
ii) Antitumor activity in breast carcinoma (MCF-7), non-small cell lung cancer (NCI-
H460), cervical carcinoma (HeLa) and hepatocellular carcinoma (HepG2) 
iii) Anti-inflammatory activity, through NO production inhibition; 
iv) Up to 400 µg/mL, the extracts did not show toxicity in non-tumor porcine liver 
cells.  
It was interesting to study the anti-inflammatory activity of H. androseamum as no previous 
studies have been reported. 5-O-caffeoylquinic acid and 3-O-caffeoylquinic acid, two 
chlorogenic acid were the most abundant phenolic compounds in the H. androseamum 
extract, while phenolic acid derivatives represent 19% of the total phenolic composition in T. 
platyphyllos extract. Protocatechuic acid and epicatechin were most abundant in T. 
platyphyllos extract while kaempferol-O-glucoside-O-rutinoside was the most abundant 
phenolic compound in E. giganteum and kaempferol derivatives represented 81% of the total 
phenolic content. E. giganteum presented fourteen phenolic compounds (two phenolic acids 
and twelve flavonol glycoside derivatives), while T. platyphyllos proved to be a more 
complex matrix in its phenolic composition, revealing the presence of thirty-three compounds. 
The results showed that these medicinal plants displayed very interesting bioactive properties 
which are related with their phenolic composition. However, further in vivo studies should be 
conducted to determine and validate the mechanism of action of these plant extracts and their 
safety, as also to be able to determine real therapeutic doses. 
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